Clinical Trial Update: Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating vaginal estradiol versus an oral beta-3 agonist for overactive bladder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Mirabegron (mirabegron)
• Vaginal Estradiol (estradiol)

Snippet

Sponsor: Walter Reed National Military Medical Center | Conditions: Overactive Bladder Syndrome | Phase 4 | Status: RECRUITING